ES2855577T3 - Molécula de ácido nucleico funcional y uso de la misma - Google Patents

Molécula de ácido nucleico funcional y uso de la misma Download PDF

Info

Publication number: ES2855577T3
Authority: ES; Spain
Prior art keywords: sequence; rna; protein; nucleic acid; acid molecule
Prior art date: 2011-03-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES12763652T

Other languages

English (en)

Spanish (es)

Inventor

Piero Carninci

Alistair Forrest

Stefano Gustincich

Claudia Carrieri

Silvia Zucchelli

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Int School For Advanced Studies

Transine Therapeutics Ltd

International School For Advanced Studies

Original Assignee

Int School For Advanced Studies

Transine Therapeutics Ltd

International School For Advanced Studies

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-30

Filing date

2012-03-30

Publication date

2021-09-23

2012-03-30 Application filed by Int School For Advanced Studies, Transine Therapeutics Ltd, International School For Advanced Studies filed Critical Int School For Advanced Studies

2021-09-23 Application granted granted Critical

2021-09-23 Publication of ES2855577T3 publication Critical patent/ES2855577T3/es

Status Active legal-status Critical Current

2032-03-30 Anticipated expiration legal-status Critical

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 106
102000039446 nucleic acids Human genes 0.000 title claims abstract description 105
108020004707 nucleic acids Proteins 0.000 title claims abstract description 105
230000000692 anti-sense effect Effects 0.000 claims abstract description 172
108090000623 proteins and genes Proteins 0.000 claims abstract description 109
230000014616 translation Effects 0.000 claims abstract description 108
102000004169 proteins and genes Human genes 0.000 claims abstract description 98
238000001243 protein synthesis Methods 0.000 claims abstract description 84
230000001965 increasing effect Effects 0.000 claims abstract description 79
239000002773 nucleotide Substances 0.000 claims abstract description 37
125000003729 nucleotide group Chemical group 0.000 claims abstract description 37
230000001105 regulatory effect Effects 0.000 claims abstract description 34
230000008685 targeting Effects 0.000 claims abstract description 23
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 144
238000000034 method Methods 0.000 claims description 43
108020004414 DNA Proteins 0.000 claims description 34
239000013604 expression vector Substances 0.000 claims description 27
238000013519 translation Methods 0.000 claims description 23
102000053602 DNA Human genes 0.000 claims description 15
230000002441 reversible effect Effects 0.000 claims description 15
108091081024 Start codon Proteins 0.000 claims description 7
239000000203 mixture Substances 0.000 claims description 7
108020003589 5' Untranslated Regions Proteins 0.000 claims description 4
230000000295 complement effect Effects 0.000 claims description 4
230000036961 partial effect Effects 0.000 claims description 4
108091023045 Untranslated Region Proteins 0.000 claims 1
230000015572 biosynthetic process Effects 0.000 abstract description 13
238000003786 synthesis reaction Methods 0.000 abstract description 10
101150038861 Uchl1 gene Proteins 0.000 description 104
210000004027 cell Anatomy 0.000 description 100
235000018102 proteins Nutrition 0.000 description 83
108020004999 messenger RNA Proteins 0.000 description 38
238000002474 experimental method Methods 0.000 description 37
102000005918 Ubiquitin Thiolesterase Human genes 0.000 description 30
108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 30
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 26
229960002930 sirolimus Drugs 0.000 description 26
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 26
230000014509 gene expression Effects 0.000 description 24
230000000694 effects Effects 0.000 description 22
239000013598 vector Substances 0.000 description 22
238000011282 treatment Methods 0.000 description 19
201000010099 disease Diseases 0.000 description 17
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
238000013518 transcription Methods 0.000 description 17
230000035897 transcription Effects 0.000 description 17
239000012634 fragment Substances 0.000 description 14
239000012636 effector Substances 0.000 description 13
108010048367 enhanced green fluorescent protein Proteins 0.000 description 13
239000004055 small Interfering RNA Substances 0.000 description 13
239000005090 green fluorescent protein Substances 0.000 description 12
210000004556 brain Anatomy 0.000 description 11
238000012217 deletion Methods 0.000 description 11
230000037430 deletion Effects 0.000 description 11
230000006870 function Effects 0.000 description 11
208000024827 Alzheimer disease Diseases 0.000 description 9
108091026898 Leader sequence (mRNA) Proteins 0.000 description 9
108091027967 Small hairpin RNA Proteins 0.000 description 9
210000000805 cytoplasm Anatomy 0.000 description 9
210000002569 neuron Anatomy 0.000 description 9
239000013612 plasmid Substances 0.000 description 9
241000699666 Mus <mouse, genus> Species 0.000 description 8
206010028980 Neoplasm Diseases 0.000 description 8
108091028043 Nucleic acid sequence Proteins 0.000 description 8
239000002299 complementary DNA Substances 0.000 description 8
238000000338 in vitro Methods 0.000 description 8
210000000130 stem cell Anatomy 0.000 description 8
230000003827 upregulation Effects 0.000 description 8
230000001419 dependent effect Effects 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
238000012546 transfer Methods 0.000 description 7
102000040650 (ribonucleotides)n+m Human genes 0.000 description 6
241000196324 Embryophyta Species 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
208000018737 Parkinson disease Diseases 0.000 description 6
108700009124 Transcription Initiation Site Proteins 0.000 description 6
230000008859 change Effects 0.000 description 6
238000007901 in situ hybridization Methods 0.000 description 6
108091026890 Coding region Proteins 0.000 description 5
108020004459 Small interfering RNA Proteins 0.000 description 5
230000001413 cellular effect Effects 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
230000001086 cytosolic effect Effects 0.000 description 5
230000007423 decrease Effects 0.000 description 5
238000010586 diagram Methods 0.000 description 5
230000004770 neurodegeneration Effects 0.000 description 5
208000015122 neurodegenerative disease Diseases 0.000 description 5
230000003252 repetitive effect Effects 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
238000001890 transfection Methods 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
108700024394 Exon Proteins 0.000 description 4
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
241000124008 Mammalia Species 0.000 description 4
240000003183 Manihot esculenta Species 0.000 description 4
238000011529 RT qPCR Methods 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
240000006394 Sorghum bicolor Species 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
230000003828 downregulation Effects 0.000 description 4
230000006698 induction Effects 0.000 description 4
210000003292 kidney cell Anatomy 0.000 description 4
108091027963 non-coding RNA Proteins 0.000 description 4
102000042567 non-coding RNA Human genes 0.000 description 4
230000008520 organization Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
238000011144 upstream manufacturing Methods 0.000 description 4
108020005544 Antisense RNA Proteins 0.000 description 3
108091032955 Bacterial small RNA Proteins 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
208000012661 Dyskinesia Diseases 0.000 description 3
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
102000008135 Mechanistic Target of Rapamycin Complex 1 Human genes 0.000 description 3
108010035196 Mechanistic Target of Rapamycin Complex 1 Proteins 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
240000007594 Oryza sativa Species 0.000 description 3
235000007164 Oryza sativa Nutrition 0.000 description 3
108091061750 Signal recognition particle RNA Proteins 0.000 description 3
235000002595 Solanum tuberosum Nutrition 0.000 description 3
244000061456 Solanum tuberosum Species 0.000 description 3
235000011684 Sorghum saccharatum Nutrition 0.000 description 3
108091036066 Three prime untranslated region Proteins 0.000 description 3
244000098338 Triticum aestivum Species 0.000 description 3
241000700605 Viruses Species 0.000 description 3
240000008042 Zea mays Species 0.000 description 3
230000004913 activation Effects 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000005860 defense response to virus Effects 0.000 description 3
210000004002 dopaminergic cell Anatomy 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
230000001722 neurochemical effect Effects 0.000 description 3
210000003523 substantia nigra Anatomy 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108091023043 Alu Element Proteins 0.000 description 2
244000144725 Amygdalus communis Species 0.000 description 2
235000011437 Amygdalus communis Nutrition 0.000 description 2
244000226021 Anacardium occidentale Species 0.000 description 2
244000099147 Ananas comosus Species 0.000 description 2
102000007272 Apoptosis Inducing Factor Human genes 0.000 description 2
108010033604 Apoptosis Inducing Factor Proteins 0.000 description 2
244000105624 Arachis hypogaea Species 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
235000009467 Carica papaya Nutrition 0.000 description 2
240000006432 Carica papaya Species 0.000 description 2
241000207199 Citrus Species 0.000 description 2
235000013162 Cocos nucifera Nutrition 0.000 description 2
244000060011 Cocos nucifera Species 0.000 description 2
101000678286 Danio rerio Eukaryotic translation initiation factor 4E-binding protein 3-like Proteins 0.000 description 2
101100447432 Danio rerio gapdh-2 gene Proteins 0.000 description 2
102000007260 Deoxyribonuclease I Human genes 0.000 description 2
108010008532 Deoxyribonuclease I Proteins 0.000 description 2
108010093668 Deubiquitinating Enzymes Proteins 0.000 description 2
101000800913 Dictyostelium discoideum Eukaryotic translation initiation factor 4E-1A-binding protein homolog Proteins 0.000 description 2
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
101000800906 Drosophila melanogaster Eukaryotic translation initiation factor 4E-binding protein Proteins 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
101150112014 Gapdh gene Proteins 0.000 description 2
235000010469 Glycine max Nutrition 0.000 description 2
244000068988 Glycine max Species 0.000 description 2
244000299507 Gossypium hirsutum Species 0.000 description 2
108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
244000020551 Helianthus annuus Species 0.000 description 2
235000003222 Helianthus annuus Nutrition 0.000 description 2
101000639063 Homo sapiens Protein UXT Proteins 0.000 description 2
235000007340 Hordeum vulgare Nutrition 0.000 description 2
240000005979 Hordeum vulgare Species 0.000 description 2
201000002832 Lewy body dementia Diseases 0.000 description 2
240000006240 Linum usitatissimum Species 0.000 description 2
235000004431 Linum usitatissimum Nutrition 0.000 description 2
239000012097 Lipofectamine 2000 Substances 0.000 description 2
240000004658 Medicago sativa Species 0.000 description 2
241000699660 Mus musculus Species 0.000 description 2
101100483636 Mus musculus Uchl1 gene Proteins 0.000 description 2
235000002637 Nicotiana tabacum Nutrition 0.000 description 2
244000061176 Nicotiana tabacum Species 0.000 description 2
240000007817 Olea europaea Species 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
244000025272 Persea americana Species 0.000 description 2
235000008673 Persea americana Nutrition 0.000 description 2
102000029301 Protein S Human genes 0.000 description 2
108010066124 Protein S Proteins 0.000 description 2
229940096437 Protein S Drugs 0.000 description 2
102100031380 Protein UXT Human genes 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
241000209056 Secale Species 0.000 description 2
102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 2
108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
244000269722 Thea sinensis Species 0.000 description 2
244000299461 Theobroma cacao Species 0.000 description 2
235000009470 Theobroma cacao Nutrition 0.000 description 2
235000021307 Triticum Nutrition 0.000 description 2
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000003321 amplification Effects 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
229940041181 antineoplastic drug Drugs 0.000 description 2
238000012231 antisense RNA technique Methods 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
235000020971 citrus fruits Nutrition 0.000 description 2
208000010877 cognitive disease Diseases 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
235000005822 corn Nutrition 0.000 description 2
230000034994 death Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
235000021186 dishes Nutrition 0.000 description 2
210000005064 dopaminergic neuron Anatomy 0.000 description 2
238000001378 electrochemiluminescence detection Methods 0.000 description 2
230000003511 endothelial effect Effects 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
230000030279 gene silencing Effects 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
210000004602 germ cell Anatomy 0.000 description 2
230000000971 hippocampal effect Effects 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
230000003993 interaction Effects 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
230000035987 intoxication Effects 0.000 description 2
231100000566 intoxication Toxicity 0.000 description 2
235000021374 legumes Nutrition 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
210000001259 mesencephalon Anatomy 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
210000001178 neural stem cell Anatomy 0.000 description 2
230000002981 neuropathic effect Effects 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
230000037361 pathway Effects 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
210000002729 polyribosome Anatomy 0.000 description 2
238000012545 processing Methods 0.000 description 2
239000000047 product Substances 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000008672 reprogramming Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
238000010839 reverse transcription Methods 0.000 description 2
238000003757 reverse transcription PCR Methods 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
235000009566 rice Nutrition 0.000 description 2
230000011664 signaling Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
210000001082 somatic cell Anatomy 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000758 substrate Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
238000002636 symptomatic treatment Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
238000001262 western blot Methods 0.000 description 2
FMKJUUQOYOHLTF-OWOJBTEDSA-N (e)-4-azaniumylbut-2-enoate Chemical compound NC\C=C\C(O)=O FMKJUUQOYOHLTF-OWOJBTEDSA-N 0.000 description 1
108020005345 3' Untranslated Regions Proteins 0.000 description 1
108020005075 5S Ribosomal RNA Proteins 0.000 description 1
102100039819 Actin, alpha cardiac muscle 1 Human genes 0.000 description 1
102100025153 Adenylate kinase 9 Human genes 0.000 description 1
102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
235000001274 Anacardium occidentale Nutrition 0.000 description 1
235000007119 Ananas comosus Nutrition 0.000 description 1
102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
235000010777 Arachis hypogaea Nutrition 0.000 description 1
239000000592 Artificial Cell Substances 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
235000007319 Avena orientalis Nutrition 0.000 description 1
244000075850 Avena orientalis Species 0.000 description 1
235000021533 Beta vulgaris Nutrition 0.000 description 1
241000335053 Beta vulgaris Species 0.000 description 1
241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
240000002791 Brassica napus Species 0.000 description 1
235000011293 Brassica napus Nutrition 0.000 description 1
235000006008 Brassica napus var napus Nutrition 0.000 description 1
240000000385 Brassica napus var. napus Species 0.000 description 1
240000008100 Brassica rapa Species 0.000 description 1
235000011292 Brassica rapa Nutrition 0.000 description 1
235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
235000004977 Brassica sinapistrum Nutrition 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
235000004936 Bromus mango Nutrition 0.000 description 1
101100190541 Caenorhabditis elegans pink-1 gene Proteins 0.000 description 1
241000282465 Canis Species 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
241000282552 Chlorocebus aethiops Species 0.000 description 1
101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
208000028698 Cognitive impairment Diseases 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
102100026139 DNA damage-inducible transcript 4 protein Human genes 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
102000001477 Deubiquitinating Enzymes Human genes 0.000 description 1
102100024746 Dihydrofolate reductase Human genes 0.000 description 1
102000011972 Dihydropyrimidinase-related protein 2 Human genes 0.000 description 1
241000255925 Diptera Species 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
108050000946 Eukaryotic translation initiation factor 4E-binding protein 1 Proteins 0.000 description 1
102100022466 Eukaryotic translation initiation factor 4E-binding protein 1 Human genes 0.000 description 1
235000008730 Ficus carica Nutrition 0.000 description 1
244000025361 Ficus carica Species 0.000 description 1
206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
235000009432 Gossypium hirsutum Nutrition 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000959247 Homo sapiens Actin, alpha cardiac muscle 1 Proteins 0.000 description 1
101001077066 Homo sapiens Adenylate kinase 9 Proteins 0.000 description 1
101000912753 Homo sapiens DNA damage-inducible transcript 4 protein Proteins 0.000 description 1
101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 1
101100483633 Homo sapiens UCHL1 gene Proteins 0.000 description 1
101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
244000017020 Ipomoea batatas Species 0.000 description 1
235000002678 Ipomoea batatas Nutrition 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
102000009784 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Human genes 0.000 description 1
108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 description 1
208000009829 Lewy Body Disease Diseases 0.000 description 1
241000209510 Liliopsida Species 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
241000208467 Macadamia Species 0.000 description 1
235000018330 Macadamia integrifolia Nutrition 0.000 description 1
240000007575 Macadamia integrifolia Species 0.000 description 1
235000014826 Mangifera indica Nutrition 0.000 description 1
240000007228 Mangifera indica Species 0.000 description 1
235000004456 Manihot esculenta Nutrition 0.000 description 1
108091027974 Mature messenger RNA Proteins 0.000 description 1
235000010624 Medicago sativa Nutrition 0.000 description 1
235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000234295 Musa Species 0.000 description 1
240000005561 Musa balbisiana Species 0.000 description 1
235000018290 Musa x paradisiaca Nutrition 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
206010029098 Neoplasm skin Diseases 0.000 description 1
206010060860 Neurological symptom Diseases 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
235000002725 Olea europaea Nutrition 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
102000008880 Peptidase C12, ubiquitin carboxyl-terminal hydrolases Human genes 0.000 description 1
108050000823 Peptidase C12, ubiquitin carboxyl-terminal hydrolases Proteins 0.000 description 1
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
235000010582 Pisum sativum Nutrition 0.000 description 1
240000004713 Pisum sativum Species 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
108091081045 Preribosomal RNA Proteins 0.000 description 1
241000508269 Psidium Species 0.000 description 1
240000001679 Psidium guajava Species 0.000 description 1
235000013929 Psidium pyriferum Nutrition 0.000 description 1
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
208000006265 Renal cell carcinoma Diseases 0.000 description 1
239000012722 SDS sample buffer Substances 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
208000000453 Skin Neoplasms Diseases 0.000 description 1
235000007230 Sorghum bicolor Nutrition 0.000 description 1
244000062793 Sorghum vulgare Species 0.000 description 1
235000009184 Spondias indica Nutrition 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
235000021536 Sugar beet Nutrition 0.000 description 1
235000006468 Thea sinensis Nutrition 0.000 description 1
208000024770 Thyroid neoplasm Diseases 0.000 description 1
239000007976 Tris-NaCl-Tween buffer Substances 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 1
102000044159 Ubiquitin Human genes 0.000 description 1
108090000848 Ubiquitin Proteins 0.000 description 1
101710186825 Ubiquitin carboxyl-terminal hydrolase isozyme L1 Proteins 0.000 description 1
102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
235000007244 Zea mays Nutrition 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
235000020224 almond Nutrition 0.000 description 1
102000003802 alpha-Synuclein Human genes 0.000 description 1
108090000185 alpha-Synuclein Proteins 0.000 description 1
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
235000021120 animal protein Nutrition 0.000 description 1
230000000648 anti-parkinson Effects 0.000 description 1
239000000939 antiparkinson agent Substances 0.000 description 1
239000002787 antisense oligonuctleotide Substances 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
238000003556 assay Methods 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
238000007622 bioinformatic analysis Methods 0.000 description 1
201000001531 bladder carcinoma Diseases 0.000 description 1
239000000872 buffer Substances 0.000 description 1
238000010805 cDNA synthesis kit Methods 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
235000020226 cashew nut Nutrition 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000001364 causal effect Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
230000019113 chromatin silencing Effects 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
108010022822 collapsin response mediator protein-2 Proteins 0.000 description 1
108091036078 conserved sequence Proteins 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
239000013601 cosmid vector Substances 0.000 description 1
244000038559 crop plants Species 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
108020001096 dihydrofolate reductase Proteins 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000004771 dopaminergic neurodegeneration Effects 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
230000005014 ectopic expression Effects 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
208000023965 endometrium neoplasm Diseases 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
241001233957 eudicotyledons Species 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
235000004426 flaxseed Nutrition 0.000 description 1
IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
238000012226 gene silencing method Methods 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
208000036260 idiopathic disease Diseases 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
201000004959 laryngeal benign neoplasm Diseases 0.000 description 1
206010023841 laryngeal neoplasm Diseases 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
208000037841 lung tumor Diseases 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000002901 mesenchymal stem cell Anatomy 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
208000027061 mild cognitive impairment Diseases 0.000 description 1
235000019713 millet Nutrition 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
229940028444 muse Drugs 0.000 description 1
230000035772 mutation Effects 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
230000016273 neuron death Effects 0.000 description 1
230000007171 neuropathology Effects 0.000 description 1
239000004090 neuroprotective agent Substances 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
201000008968 osteosarcoma Diseases 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
108091005618 oxidative modified proteins Proteins 0.000 description 1
108091075611 p53 family Proteins 0.000 description 1
102000041788 p53 family Human genes 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
102000045222 parkin Human genes 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
235000020232 peanut Nutrition 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
235000012015 potatoes Nutrition 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
208000023958 prostate neoplasm Diseases 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000000717 sertoli cell Anatomy 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
210000001988 somatic stem cell Anatomy 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000037351 starvation Effects 0.000 description 1
230000002739 subcortical effect Effects 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
230000003977 synaptic function Effects 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
208000013076 thyroid tumor Diseases 0.000 description 1
230000005758 transcription activity Effects 0.000 description 1
238000012033 transcriptional gene silencing Methods 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000003146 transient transfection Methods 0.000 description 1
230000005945 translocation Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
239000000225 tumor suppressor protein Substances 0.000 description 1
ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 description 1
MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
208000010570 urinary bladder carcinoma Diseases 0.000 description 1
208000024719 uterine cervix neoplasm Diseases 0.000 description 1
230000002792 vascular Effects 0.000 description 1
208000019553 vascular disease Diseases 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Developing Agents For Electrophotography (AREA)

ES12763652T 2011-03-30 2012-03-30 Molécula de ácido nucleico funcional y uso de la misma Active ES2855577T3 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161469399P	2011-03-30	2011-03-30
PCT/JP2012/059430 WO2012133947A1 (fr)	2011-03-30	2012-03-30	Molécule d'acide nucléique fonctionnelle et ses applications

Publications (1)

Publication Number	Publication Date
ES2855577T3 true ES2855577T3 (es)	2021-09-23

Family

ID=46931619

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES12763652T Active ES2855577T3 (es)	2011-03-30	2012-03-30	Molécula de ácido nucleico funcional y uso de la misma

Country Status (5)

Country	Link
US (1)	US9353370B2 (fr)
EP (2)	EP2691522B1 (fr)
JP (3)	JP2014514921A (fr)
ES (1)	ES2855577T3 (fr)
WO (1)	WO2012133947A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105624156B (zh) *	2014-11-04	2021-07-16	清华大学	含有反向sineb2重复序列的人工非编码rna及其在增强靶蛋白翻译中的用途
IT201700105372A1 (it) *	2017-09-20	2019-03-20	Fondazione St Italiano Tecnologia	Molecola di acido nucleico funzionale e relativo uso
IT201800002411A1 (it)	2018-02-05	2019-08-05	Scuola Int Superiore Di Studi Avanzati Sissa	Domini strutturali di molecole di rna antisenso che aumentano la traduzione
IT201900011490A1 (it)	2019-07-11	2021-01-11	Scuola Int Superiore Di Studi Avanzati Sissa	MOLECOLE DI ACIDO NUCLEICO FUNZIONALI CHE AUMENTANO LA TRADUZIONE DI UN mRNA DELLA FRATASSINA
WO2021046243A2 (fr)	2019-09-03	2021-03-11	Myeloid Therapeutics, Inc.	Méthodes et compositions d'intégration génomique
KR20230128446A (ko) *	2020-09-24	2023-09-05	폰다치오네 이스티튜토 이탈리아노 디 테크놀로지아	변형된 기능적 핵산 분자
WO2022074396A1 (fr)	2020-10-08	2022-04-14	Transine Therapeutics Limited	Molécules d'acide nucléique fonctionnelles
EP3992289A1 (fr)	2020-10-30	2022-05-04	Transine Therapeutics Limited	Molécules d'acide nucléique fonctionnelles comprenant des domaines de liaison de protéines
EP4280347B1 (fr)	2021-01-18	2025-05-14	IBIDEN Co., Ltd.	Feuille de suppression de transfert de chaleur pour bloc-batterie, et bloc-batterie
EP4063505A1 (fr)	2021-03-22	2022-09-28	Fondazione Istituto Italiano di Tecnologia	Molécules d'acide nucléique fonctionnelles dirigées vers des cibles pour des troubles du système nerveux
WO2022214635A1 (fr)	2021-04-08	2022-10-13	Stichting Vu	Molécules d'acide nucléique de compensation de l'haplo-insuffisance stxbp1 et leur utilisation dans le traitement de troubles liés à stxbp1
KR20240037192A (ko)	2021-05-11	2024-03-21	마이얼로이드 테라퓨틱스, 인크.	게놈 통합을 위한 방법 및 조성물
GB202205423D0 (en)	2022-04-12	2022-05-25	Transine Therapeutics Ltd	Functional nucleic acid molecule
GB202207795D0 (en)	2022-05-26	2022-07-13	Fondazione St Italiano Tecnologia	Functional nucleic acid molecule
GB202207796D0 (en)	2022-05-26	2022-07-13	Fondazione St Italiano Tecnologia	Functional nucleic acid molecule
IT202200011546A1 (it)	2022-06-01	2022-09-01	Univ Degli Studi Di Trento	Sequenze di RNA non codificanti in grado di aumentare l'espressione delle proteine CHD8 e CHD2
WO2025133858A1 (fr)	2023-12-18	2025-06-26	Fondazione Istituto Italiano Di Tecnologia	Molécule d'acide nucléique fonctionnelle pouvant augmenter la production de bdnf

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5807715A (en)	1984-08-27	1998-09-15	The Board Of Trustees Of The Leland Stanford Junior University	Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
CA2857880A1 (fr) *	2004-11-12	2006-12-28	Asuragen, Inc.	Procedes et compositions comprenant des molecules de micro-arn et des molecules d'inhibiteur de micro-arn
EA018039B1 (ru)	2005-12-13	2013-05-30	Киото Юниверсити	Ядерный фактор перепрограммирования
EP2152873A2 (fr) *	2007-03-16	2010-02-17	Biorigen S.r.l	Technique de regulation de l'expression genetique et arn non codant a visee diagnostique et therapeutique
EP2235180B1 (fr) *	2007-12-28	2011-11-09	Qiagen Sciences, Inc.	Régulation positive induisant l'apoptose dans des expériences de modulation d'expression
JP2010273680A (ja)	2009-05-29	2010-12-09	Kyoto Univ	初期化因子が除去された人工多能性幹細胞の作製方法
JP5696282B2 (ja)	2009-06-10	2015-04-08	国立大学法人京都大学	人工多能性幹細胞樹立効率改善剤
JP2011004674A (ja)	2009-06-26	2011-01-13	Fujitsu Ltd	誘導多能性幹細胞（ｉＰＳ細胞）の製造方法
JP5751548B2 (ja)	2009-08-07	2015-07-22	国立大学法人京都大学	イヌｉＰＳ細胞及びその製造方法

2012
- 2012-03-30 WO PCT/JP2012/059430 patent/WO2012133947A1/fr not_active Ceased
- 2012-03-30 US US14/008,186 patent/US9353370B2/en active Active
- 2012-03-30 EP EP12763652.0A patent/EP2691522B1/fr active Active
- 2012-03-30 ES ES12763652T patent/ES2855577T3/es active Active
- 2012-03-30 EP EP20203177.9A patent/EP3792359A1/fr active Pending
- 2012-03-30 JP JP2014501947A patent/JP2014514921A/ja active Pending
2017
- 2017-04-19 JP JP2017083227A patent/JP6770921B2/ja active Active
2020
- 2020-09-28 JP JP2020162110A patent/JP7229487B2/ja active Active

Also Published As

Publication number	Publication date
EP2691522A4 (fr)	2014-11-05
EP2691522B1 (fr)	2020-11-25
WO2012133947A1 (fr)	2012-10-04
US9353370B2 (en)	2016-05-31
EP2691522A1 (fr)	2014-02-05
EP3792359A1 (fr)	2021-03-17
US20140107187A1 (en)	2014-04-17
JP2014514921A (ja)	2014-06-26
JP2017169573A (ja)	2017-09-28
JP6770921B2 (ja)	2020-10-21
JP7229487B2 (ja)	2023-02-28
JP2021006047A (ja)	2021-01-21

Publication	Publication Date	Title
ES2855577T3 (es)	2021-09-23	Molécula de ácido nucleico funcional y uso de la misma
Alexander et al.	2013	MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation
Faghihi et al.	2010	Evidence for natural antisense transcript-mediated inhibition of microRNA function
Liu et al.	2012	MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice
Xu et al.	2013	miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1
Bon et al.	2019	SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia
ES2659845B1 (es)	2019-01-04	Modulación de microRNAs contra la distrofia miotónica tipo 1 y antagonistas de microRNAs para ello
Lu et al.	2019	lncRNA‐CIR regulates cell apoptosis of chondrocytes in osteoarthritis
Church et al.	2017	Microprocessor recruitment to elongating RNA polymerase II is required for differential expression of microRNAs
Overby et al.	2022	Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
Lee et al.	2015	Altered expression of miR-202 in cerebellum of multiple-system atrophy
WO2016113544A1 (fr)	2016-07-21	Traitement de maladies associées au dysfonctionnement des mitochondries
Meseguer et al.	2022	mt tRFs, new players in MELAS disease
JP2010184879A (ja)	2010-08-26	抗筋萎縮剤
Xu et al.	2009	cAMP-mediated stimulation of tyrosine hydroxylase mRNA translation is mediated by polypyrimidine-rich sequences within its 3′-untranslated region and poly (C)-binding protein 2
JP7776924B2 (ja)	2025-11-27	変異ＦＵＳの発現を選択的に抑制する修飾ｓｉＲＮＡ
Zheng et al.	2017	Autoantigen La regulates microRNA processing from stem–loop precursors by association with DGCR8
Yu et al.	2010	Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1
CN115873935B (zh)	2025-11-25	Hilnc或包含其的信号通路作为调控脂质代谢的靶标的应用
WO2020002691A1 (fr)	2020-01-02	Traitement de la cardiomyopathie par modulation de l'activité erna induite par l'hypoxie
Yang et al.	2009	The molecular mechanism regulating the autonomous circadian expression of Topoisomerase I in NIH3T3 cells
Niimi et al.	2009	Involvement of an alternatively spliced mitochondrial oxodicarboxylate carrier in adipogenesis in 3T3-L1 cells
Pierattini	2022	SINEUP lncRNAs: from molecular mechanism to therapeutic application.
Sirey et al.	2018	Cerox1 and microRNA-488-3p noncoding RNAs jointly regulate mitochondrial complex I catalytic activity
Rybarikova et al.	2025	Gene editing for Spinocerebellar ataxia type 3 taking advantage of the human ATXN3L paralog as replacement gene